Lung health: It has demonstrated lung-protective activities in animal models of fibrotic lung disease, COPD, acute lung injury, and asthma, where it was found to reduce inflammation and fibrosis [2,1113]
Initially developed as a medication to manage type 2 diabetes, GLP-1 injections have demonstrated efficacy in promoting weight loss when administered specifically for this purpose
This allows the medication to be used at a convenient time and provides a more predictable result
COLLAGEN & AMINO ACIDS: Provides a full amino acid profile from grass-fed bovine collagen hydrolysate
Its key that employers and brokers: Decide if and how your plan will cover GLP-1s, and if so, whether for cardiometabolic diseases (including diabetes), weight loss, or both